Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 23, 2024

BUY
$29.93 - $35.06 $262,575 - $307,581
8,773 New
8,773 $295 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.91B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track City Center Advisors, LLC Portfolio

Follow City Center Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of City Center Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on City Center Advisors, LLC with notifications on news.